Related Experiment Video
Updated: May 26, 2026

Erosion Identification in Metacarpophalangeal Joints in Rheumatoid Arthritis using High-Resolution Peripheral Quantitative Computed Tomography
Published on: October 6, 2023
Identification of State-Level Disparities in the Supply, Demand, and Adequacy of Rheumatologists in the United States
Jason Silvestre1, Robert J Ferdon1, Robert A Ravinsky1
1Medical University of South Carolina, Charleston.
Objective:
Previous research has addressed whether the rheumatologist workforce is adequate to meet future demand. This study analyzed geographic disparities in the supply, demand, and workforce adequacy of rheumatologists across the United States.
Methods:
This was a microsimulation of rheumatologists using the Health Workforce Simulation Model for the years 2025 to 2037. Supply and demand were defined as the number of full-time equivalent (FTE) rheumatologists working and required, respectively. Workforce adequacy was defined as the ratio of supply over demand. Workforce trends over the study period were analyzed with linear regression, and disparities were analyzed with chi-square tests.
Results:
By 2037, rheumatologist supply was projected at 7,600 FTEs in metropolitan areas, whereas demand was projected at 7,810 FTEs (97.3% adequacy). In contrast, rheumatologist supply was projected at 210 FTEs in nonmetropolitan areas, whereas demand was projected at 1,190 FTEs (18.5% adequacy) (P < 0.001). By 2037, rheumatologist workforce adequacy was projected to be lowest in the South (73.4%) and highest in the Northeast (128%) (P < 0.001). The states with the lowest projected rheumatologist adequacies were Idaho (14.3%), West Virginia (33.3%), Nevada (44.4%), Arizona (45.8%), Arkansas (50.0%), and Wyoming (50.0%).
Conclusion:
Deficiencies in the rheumatologist workforce are projected to 2037, with a notable maldistribution affecting nonmetropolitan areas, the South, and certain identified states. Further efforts are needed to implement strategies that enhance rheumatologist workforce adequacy in areas with identified deficiencies.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Rheumatic Heart Disease I: Introduction
The JAK-STAT Signaling Pathway